Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bornemann KD"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mould AW; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, United Kingdom., Wright DJ; Earlham Institute, Norwich Research Park, Norwich NR4 7UZ, United Kingdom., Bornemann KD; Boehringer Ingelheim Pharma GmbH & Co. KG, 65 Birkendorfer Straße, 88397, Biberach an der Riß, Germany., Hengerer B; Boehringer Ingelheim Pharma GmbH & Co. KG, 65 Birkendorfer Straße, 88397, Biberach an der Riß, Germany., Pinnock R; Biogen Idec Ltd, 5 Roxborough Way, Maidenhead SL6 3UD, United Kingdom., Drydale E; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, United Kingdom., Bancroft J; Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, United Kingdom., Hall NAL; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, United Kingdom., von Delft A; Centre for Medicines Discovery, NDM Research Building, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, United Kingdom., Brennan PE; Alzheimer's Research UK Oxford Drug Discovery Institute, Centre for Medicines Discovery, NDM Research Building, University of Oxford, Roosevelt Drive, Oxford OX3 7FZ, United Kingdom., Harrison PJ; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, United Kingdom., Haerty W; Earlham Institute, Norwich Research Park, Norwich NR4 7UZ, United Kingdom.; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, United Kingdom., Tunbridge EM; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, United Kingdom.; Boehringer Ingelheim Pharma GmbH & Co. KG, 65 Birkendorfer Straße, 88397, Biberach an der Riß, Germany.
Publikováno v:
Cerebral cortex (New York, N.Y. : 1991) [Cereb Cortex] 2024 Dec 03; Vol. 34 (12).
Autor:
Poggi G; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Bergamini G; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Dulinskas R; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Madur L; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland.; Zurich Neuroscience Center, University of Zurich and Swiss Federal Institute of Technology, Zurich, Zurich, Switzerland., Greter A; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Ineichen C; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Dagostino A; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Kúkeľová D; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Sigrist H; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Bornemann KD; CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hengerer B; CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Pryce CR; Preclinical Laboratory for Translational Research into Affective Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland.; Zurich Neuroscience Center, University of Zurich and Swiss Federal Institute of Technology, Zurich, Zurich, Switzerland.
Publikováno v:
The European journal of neuroscience [Eur J Neurosci] 2024 Mar; Vol. 59 (5), pp. 996-1015. Date of Electronic Publication: 2024 Feb 07.
Autor:
Madur L; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland.; Zurich Neuroscience Center, University of Zurich and ETH Zurich, Zurich, Switzerland., Ineichen C; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Bergamini G; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Greter A; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Poggi G; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Cuomo-Haymour N; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland.; Zurich Neuroscience Center, University of Zurich and ETH Zurich, Zurich, Switzerland., Sigrist H; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland., Sych Y; Institute of Cellular and Integrative Neuroscience, University of Strasbourg, Strasbourg, France., Paterna JC; Viral Vector Facility, University of Zurich and ETH Zurich, Zurich, Switzerland., Bornemann KD; CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Viollet C; Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Fernandez-Albert F; Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Alanis-Lobato G; Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hengerer B; CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Pryce CR; Preclinical Laboratory, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zürich (PUK) and University of Zurich (UZH), Zurich, Switzerland. christopher.pryce@bli.uzh.ch.; Zurich Neuroscience Center, University of Zurich and ETH Zurich, Zurich, Switzerland. christopher.pryce@bli.uzh.ch.
Publikováno v:
Communications biology [Commun Biol] 2023 Apr 15; Vol. 6 (1), pp. 422. Date of Electronic Publication: 2023 Apr 15.
Autor:
Deacon RM; Department of Experimental Psychology, University of Oxford, South Parks Road, Oxford OX1 3UD, UK. robert.deacon@psy.ox.ac.uk, Koros E, Bornemann KD, Rawlins JN
Publikováno v:
Behavioural brain research [Behav Brain Res] 2009 Feb 11; Vol. 197 (2), pp. 466-8. Date of Electronic Publication: 2008 Oct 11.
Autor:
Deacon RM; Department of Experimental Psychology, University of Oxford, South Parks Road, Oxford OX1 3UD, UK. robert.deacon@psy.ox.ac.uk, Cholerton LL, Talbot K, Nair-Roberts RG, Sanderson DJ, Romberg C, Koros E, Bornemann KD, Rawlins JN
Publikováno v:
Behavioural brain research [Behav Brain Res] 2008 May 16; Vol. 189 (1), pp. 126-38. Date of Electronic Publication: 2008 Jan 05.